Patterns of metabolic progression to type 1 diabetes in the Diabetes Prevention Trial-Type 1.
暂无分享,去创建一个
J. Krischer | H. Chase | N. White | C. Cowie | B. Buckingham | K. Herold | J. Skyler | C. Greenbaum | J. Palmer | J. Sosenko | J. Mahon | D. Cuthbertson | Bruce Buckingham
[1] C. Valeri,et al. No evidence for genetically determined alteration in insulin secretion or sensitivity predisposing to type 1 diabetes: a study of identical twins. , 2005, Diabetes care.
[2] O. Faber,et al. B-cell function and blood glucose control in insulin dependent diabetics within the first month of insulin treatment , 1977, Diabetologia.
[3] L. Harrison,et al. Insulin resistance is a risk factor for progression to Type 1 diabetes , 2004, Diabetologia.
[4] M. Rewers,et al. Clinical characteristics of children diagnosed with type 1 diabetes through intensive screening and follow-up. , 2004, Diabetes care.
[5] J. Ilonen,et al. Natural history of preclinical IDDM in high risk siblings , 1994, Diabetologia.
[6] S. Brink,et al. Predictive value of intravenous glucose tolerance test insulin secretion less than or greater than the first percentile in islet cell antibody positive relatives of Type 1 (insulin-dependent) diabetic patients , 1991, Diabetologia.
[7] Å. Lernmark,et al. The Fourth International Serum Exchange Workshop to standardize cytoplasmic islet cell antibodies , 1991, Diabetologia.
[8] K. Alberti,et al. Impaired glucose tolerance precedes but does not predict insulin-dependent diabetes mellitus: a study of identical twins , 1990, Diabetologia.
[9] Å. Lernmark,et al. Islet cell and other organ-specific autoantibodies in all children developing Type 1 (insulin-dependent) diabetes mellitus in Sweden during one year and in matched control children , 1989, Diabetologia.
[10] G. A. Fleming,et al. C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001. , 2004, Diabetes.
[11] M. Steffes,et al. Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial. , 2003, Diabetes care.
[12] Carla J Greenbaum,et al. Insulin resistance in type 1 diabetes , 2002, Diabetes/metabolism research and reviews.
[13] C. Greenbaum,et al. Type I diabetes manifested solely by 2-h oral glucose tolerance test criteria. , 2001, Diabetes.
[14] P. Bingley,et al. Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop. , 1998, Diabetes.
[15] M. Knip,et al. Poor Beta‐cell Function After the Clinical Manifestation of Type 1 Diabetes in Children Initially Positive for Islet Cell Specific Autoantibodies , 1997, Diabetic medicine : a journal of the British Diabetic Association.
[16] F. Pociot,et al. Genetic susceptibility markers in Danish patients with type 1 (insulin-dependent) diabetes : evidence for polygenecity in man , 1994 .
[17] L. Kuller,et al. Familial and sporadic insulin-dependent diabetes: evidence for heterogeneous etiologies? , 1991, Diabetes research and clinical practice.
[18] J. Krischer,et al. A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes. , 1990, The New England journal of medicine.
[19] A. Ziegler,et al. Predicting Type I Diabetes , 1990, Diabetes Care.
[20] E. Bonifacio,et al. Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes , 1990, The Lancet.
[21] A. Ziegler,et al. Life-Table Analysis of Progression to Diabetes of Anti-Insulin Autoantibody-Positive Relatives of Individuals With Type I Diabetes , 1989, Diabetes.
[22] H. Valkenburg,et al. TEN-YEAR FOLLOW-UP STUDY OF ISLET-CELL ANTIBODIES AND CHILDHOOD DIABETES MELLITUS , 1989, The Lancet.
[23] M. Sharf,et al. Fetal obstructive uropathy [corrected]. , 1988, Lancet.
[24] H. Chase,et al. Diagnosis of pre-type I diabetes. , 1987, The Journal of pediatrics.
[25] G. Eisenbarth,et al. Competitive Insulin Autoantibody Assay: Prospective Evaluation of Subjects at High Risk for Development of Type I Diabetes Mellitus , 1987, Diabetes.
[26] E. Gale,et al. Type I (insulin dependent) diabetes: a disease of slow clinical onset? , 1987, British medical journal.
[27] S. Yagihashi,et al. Triad of markers for identifying children at high risk of developing insulin-dependent diabetes mellitus. , 1985, JAMA.
[28] G. Eisenbarth,et al. First-degree relatives of patients with type I diabetes mellitus. Islet-cell antibodies and abnormal insulin secretion. , 1985, The New England journal of medicine.
[29] N. Maclaren,et al. Ten-Year Prognosis of Impaired Glucose Tolerance in Siblings of Patients with Insulin-dependent Diabetes , 1982, Diabetes.
[30] J. McNally,et al. EVIDENCE FOR A LONG PREDIABETIC PERIOD IN TYPE I (INSULIN-DEPENDENT) DIABETES MELLITUS , 1981, The Lancet.
[31] D. Lezotte,et al. Islet Cell and Other Organ-specific Antibodies in U.S. Caucasians and Blacks with Insulin-dependent Diabetes Mellitus , 1980, Diabetes.
[32] D. R. Gamble,et al. ISLET-CELL ANTIBODIES IN DIABETES MELLITUS , 1976, The Lancet.
[33] M. Parent,et al. Letter: Dinitrochlorobenzene sensitisation in congenital syphilis. , 1973, Lancet.